Endologix Company Profile (NASDAQ:ELGX)

About Endologix

Endologix logoEndologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ELGX
  • CUSIP: 29266S10
Key Metrics:
  • Previous Close: $12.73
  • 50 Day Moving Average: $12.22
  • 200 Day Moving Average: $11.69
  • 52-Week Range: $6.51 - $14.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.29
  • P/E Growth: -0.47
  • Market Cap: $1.05B
  • Outstanding Shares: 82,372,000
  • Beta: 0.82
Profitability:
  • Net Margins: -82.39%
  • Return on Equity: -41.88%
  • Return on Assets: -14.85%
Debt:
  • Debt-to-Equity Ratio: 1.19%
  • Current Ratio: 2.63%
  • Quick Ratio: 1.92%
Additional Links:
Companies Related to Endologix:

Analyst Ratings

Consensus Ratings for Endologix (NASDAQ:ELGX) (?)
Ratings Breakdown: 3 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $13.79 (8.34% upside)

Analysts' Ratings History for Endologix (NASDAQ:ELGX)
Show:
DateFirmActionRatingPrice TargetDetails
9/17/2016Leerink SwannSet Price TargetHold$13.00View Rating Details
8/3/2016BMO Capital MarketsReiterated RatingBuy$15.00View Rating Details
8/3/2016BTIG ResearchReiterated RatingBuy$16.00View Rating Details
8/3/2016Piper Jaffray Cos.Reiterated RatingOverweight$15.00View Rating Details
8/3/2016Oppenheimer Holdings Inc.Set Price TargetBuy$16.00 -> $15.00View Rating Details
8/3/2016RBC Capital MarketsDowngradeOutperform -> Sector Perform$17.00 -> $12.00View Rating Details
8/3/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$17.00 -> $12.00View Rating Details
7/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$16.00View Rating Details
4/4/2016JPMorgan Chase & Co.Initiated CoverageOverweight$11.00View Rating Details
2/22/2016Credit Suisse Group AGLower Price TargetOutperform$16.00 -> $10.00View Rating Details
2/2/2016Stifel NicolausLower Price TargetBuy$17.00 -> $15.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Endologix (NASDAQ:ELGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2016        
8/2/2016Q2($0.20)($0.13)$46.30 million$51.00 millionViewListenView Earnings Details
5/9/2016Q1($0.24)($0.25)$38.78 million$42.40 millionViewN/AView Earnings Details
2/22/2016Q4($0.16)($0.17)$39.97 million$39.20 millionViewListenView Earnings Details
10/26/2015Q315($0.14)($0.13)$38.12 million$38.20 millionViewListenView Earnings Details
8/3/2015Q215($0.13)($0.18)$39.47 million$39.50 millionViewN/AView Earnings Details
4/29/2015Q115($0.13)($0.14)$37.94 million$36.70 millionViewN/AView Earnings Details
2/25/2015Q414($0.10)($0.11)$38.10 million$38.80 millionViewN/AView Earnings Details
10/30/2014Q314($0.13)($0.13)$37.00 million$37.20 millionViewListenView Earnings Details
7/30/2014Q214($0.08)($0.06)$36.50 million$38.30 millionViewListenView Earnings Details
4/30/2014Q114($0.08)($0.08)$32.24 million$33.30 millionViewListenView Earnings Details
2/27/2014Q413($0.05)($0.05)$35.80 million$35.25 millionViewListenView Earnings Details
10/30/2013Q313($0.05)$0.01$32.47 million$33.30 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.06)($0.03)$33.94 million$34.00 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.06)($0.15)$29.26 million$29.80 millionViewN/AView Earnings Details
2/27/2013Q4 2012($0.03)($0.09)$29.03 million$29.22 millionViewN/AView Earnings Details
10/25/2012($0.04)($0.03)ViewN/AView Earnings Details
7/26/2012($0.04)($0.09)ViewN/AView Earnings Details
4/26/2012($0.06)($0.07)ViewN/AView Earnings Details
2/22/2012($0.05)($0.06)ViewN/AView Earnings Details
10/27/2011($0.05)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endologix (NASDAQ:ELGX)
Current Year EPS Consensus Estimate: $-0.74 EPS
Next Year EPS Consensus Estimate: $-0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.24)($0.24)($0.24)
Q2 20161($0.22)($0.22)($0.22)
Q3 20162($0.17)($0.17)($0.17)
Q4 20162($0.16)($0.13)($0.15)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.12)($0.12)($0.12)
Q4 20171($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endologix (NASDAQ:ELGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endologix (NASDAQ:ELGX)
Insider Ownership Percentage: 3.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2016Jose A LimaVPSell4,710$11.68$55,012.80View SEC Filing  
8/5/2016Michael V ChobotovInsiderSell14,000$12.40$173,600.00View SEC Filing  
6/3/2016Gregory D WallerDirectorSell7,800$12.86$100,308.00View SEC Filing  
6/1/2016Amanda L DepalmaVPSell689$12.55$8,646.95View SEC Filing  
6/1/2016John D McdermottCEOSell6,116$12.55$76,755.80View SEC Filing  
6/1/2016Joseph A DejohnInsiderSell957$12.55$12,010.35View SEC Filing  
6/1/2016Robert D MitchellPresidentSell2,294$12.55$28,789.70View SEC Filing  
5/26/2016James Edward MachekVPSell6,500$12.76$82,940.00View SEC Filing  
1/26/2016Charles Steele LoveVPSell4,280$7.72$33,041.60View SEC Filing  
11/3/2015Guido J NeelsDirectorBuy11,000$9.32$102,520.00View SEC Filing  
11/3/2015Todd AbrahamVPBuy2,500$8.85$22,125.00View SEC Filing  
11/2/2015John D McdermottCEOBuy20,000$8.90$178,000.00View SEC Filing  
9/3/2015Jose A LimaVPSell1,923$12.60$24,229.80View SEC Filing  
5/26/2015Thomas WilderDirectorSell3,790$16.08$60,943.20View SEC Filing  
5/20/2015Jose A LimaVPSell1,872$16.75$31,356.00View SEC Filing  
4/6/2015Robert D MitchellPresidentSell45,000$17.33$779,850.00View SEC Filing  
12/12/2014Charles Steele LoveVPSell10,000$13.95$139,500.00View SEC Filing  
11/18/2014Charles Steele LoveVPBuy2,000$11.70$23,400.00View SEC Filing  
11/4/2014Guido J NeelsDirectorBuy10,000$11.21$112,100.00View SEC Filing  
11/4/2014John D McdermottCEOBuy25,000$11.25$281,250.00View SEC Filing  
8/4/2014Thomas WilderDirectorSell3,500$13.68$47,880.00View SEC Filing  
6/12/2014Robert D MitchellPresidentSell18,271$14.23$259,996.33View SEC Filing  
6/10/2014Robert D MitchellPresidentSell8,516$14.20$120,927.20View SEC Filing  
8/14/2013Stefan SchreckVPSell25,000$16.18$404,500.00View SEC Filing  
8/13/2013Stefan SchreckVPSell29,000$15.88$460,520.00View SEC Filing  
8/5/2013Gary SorsherVPSell12,483$15.98$199,478.34View SEC Filing  
8/5/2013John McdermottCEOSell165,000$16.00$2,640,000.00View SEC Filing  
8/2/2013Todd AbrahamVPSell9,994$15.90$158,904.60View SEC Filing  
8/1/2013John D McdermottCEOSell15,000$15.83$237,450.00View SEC Filing  
6/3/2013Thomas WilderDirectorSell22,500$13.25$298,125.00View SEC Filing  
5/28/2013Leonard M GreensteinVPSell1,253$14.01$17,554.53View SEC Filing  
12/28/2012Robert John KristCFOSell37,530$14.06$527,671.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Endologix (NASDAQ:ELGX)
DateHeadline
News IconAre Analysts Bearish Endologix, Inc. (NASDAQ:ELGX) After Last Week? - Post News (NASDAQ:ELGX)
www.kentuckypostnews.com - September 26 at 9:31 AM
investornewswire.com logoCan Endologix, Inc. (NASDAQ:ELGX) Surprise Analysts This Quarter? - Investor Newswire (NASDAQ:ELGX)
www.investornewswire.com - September 25 at 4:21 PM
News IconWhich way Endologix Inc. (NASDAQ:ELGX) earnings may go | Voice ... - The Voice Registrar (NASDAQ:ELGX)
voiceregistrar.com - September 23 at 4:33 PM
streetinsider.com logoEndologix (ELGX) Announces Ovation LIFE Study Met Primary Endpoint in AAA (NASDAQ:ELGX)
www.streetinsider.com - September 21 at 5:21 PM
streetinsider.com logoEndologix (ELGX) Announces Ovation LIFE Study Met Primary ... - StreetInsider.com (NASDAQ:ELGX)
www.streetinsider.com - September 21 at 8:45 AM
capitalcube.com logoEndologix, Inc. – Value Analysis (NASDAQ:ELGX) : September 20, 2016 (NASDAQ:ELGX)
www.capitalcube.com - September 21 at 8:45 AM
finance.yahoo.com logo12:10 pm Endologix announces that the Ovation LIFE study met the primary endpoint for major adverse events in a late breaking session at Vascular InterVentional Advances (NASDAQ:ELGX)
finance.yahoo.com - September 21 at 8:45 AM
finance.yahoo.com logoEndologix Reports Positive Clinical Data from Ovation® LIFE (Least Invasive Fast-Track EVAR) Study (NASDAQ:ELGX)
finance.yahoo.com - September 21 at 8:45 AM
feeds.reuters.com logoBRIEF-Endologix reports positive clinical data from Ovation Life study (NASDAQ:ELGX)
feeds.reuters.com - September 20 at 12:45 PM
capitalcube.com logoEndologix, Inc. breached its 50 day moving average in a Bullish Manner : ELGX-US : September 19, 2016 (NASDAQ:ELGX)
www.capitalcube.com - September 19 at 9:29 AM
News IconEndologix, Inc.'s Trend Up, Especially After Forming a Bullish Double Top Chart Pattern - Chester News (NASDAQ:ELGX)
www.chesterindependent.com - September 16 at 8:32 AM
News IconConsensus Take: Endologix, Inc. (NASDAQ:ELGX) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:ELGX)
friscofastball.com - September 13 at 9:41 AM
News Icon2 Stocks Analyst-Opinion Need Close Attention Endologix, Inc. (NASDAQ:ELGX), Gramercy Property Trust (NYSE:GPT) - The Voice Registrar (NASDAQ:ELGX)
voiceregistrar.com - September 8 at 8:37 AM
capitalcube.com logoETF’s with exposure to Endologix, Inc. : September 6, 2016 (NASDAQ:ELGX)
www.capitalcube.com - September 6 at 4:41 PM
globenewswire.com logoEndologix to Participate in Two Investor Conferences in September 2016 - GlobeNewswire (press release) (NASDAQ:ELGX)
globenewswire.com - September 6 at 9:40 AM
finance.yahoo.com logoEndologix to Participate in Two Investor Conferences in September 2016 (NASDAQ:ELGX)
finance.yahoo.com - September 6 at 9:40 AM
bizjournals.com logoResearch Reports Coverage on Medical Instruments & Supplies Stocks -- DENTSPLY Intl., Endologix, OraSure Technologies, and TransEnterix (NASDAQ:ELGX)
www.bizjournals.com - September 2 at 9:41 AM
News IconShares Slipping Lower Over the Past Month: Endologix Inc. (NASDAQ:ELGX) - Post News (NASDAQ:ELGX)
www.kentuckypostnews.com - September 1 at 7:31 AM
News IconEndologix Inc. (NASDAQ:ELGX) missed earnings on 4 occasions - The Independent Republic (NASDAQ:ELGX)
theindependentrepublic.com - August 27 at 9:04 AM
News IconEndologix Inc. (NASDAQ:ELGX) To Report September 2016 Results - The Voice Registrar (NASDAQ:ELGX)
voiceregistrar.com - August 25 at 4:53 PM
News IconRetail & Analyst Ratings Forecasts on Endologix, Inc. (NASDAQ:ELGX) - Post News (NASDAQ:ELGX)
www.kentuckypostnews.com - August 23 at 9:05 AM
zacks.com logoEndologix's Ovation Alto System Treats First Patients (NASDAQ:ELGX)
www.zacks.com - August 22 at 9:27 AM
News IconStocks Preparing To Gain Concentrations- Endologix Inc. (NASDAQ ... - Seneca Globe (NASDAQ:ELGX)
www.senecaglobe.com - August 18 at 10:10 PM
streetinsider.com logoEndologix (ELGX) Announces Treatment of First AAA Patients with Ovation Alto ASGS (NASDAQ:ELGX)
www.streetinsider.com - August 18 at 4:51 PM
streetinsider.com logoEndologix (ELGX) Announces Treatment of First AAA Patients with ... - StreetInsider.com (NASDAQ:ELGX)
www.streetinsider.com - August 18 at 6:55 AM
News IconEndologix Announces First Patients Treated with Ovation Alto Abdominal Stent Graft System (NASDAQ:ELGX)
www.pressreleasepoint.com - August 17 at 5:01 PM
publicnow.com logoEndologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System (NASDAQ:ELGX)
www.publicnow.com - August 17 at 5:01 PM
investornewswire.com logoEarnings Surprise In Focus: Endologix, Inc. (NASDAQ:ELGX) - Investor Newswire (NASDAQ:ELGX)
www.investornewswire.com - August 17 at 6:52 AM
finance.yahoo.com logoENDOLOGIX INC /DE/ Financials (NASDAQ:ELGX)
finance.yahoo.com - August 16 at 4:51 PM
fidaily.com logoArrowpoint Asset Management, LLC Buys A Lot More Endologix, Inc. (ELGX) Stock Last Quarter - Finance Daily (NASDAQ:ELGX)
www.fidaily.com - August 15 at 4:56 PM
fidaily.com logoEndologix, Inc. (ELGX) Holdings Down in Latest Report from Cadian Capital Management, Lp - Finance Daily (NASDAQ:ELGX)
www.fidaily.com - August 12 at 4:50 PM
istreetwire.com logoStocks Buzz: Endologix Inc. (ELGX) F.N.B. Corporation (FNB) UDR, Inc. (UDR) - iStreetWire (NASDAQ:ELGX)
istreetwire.com - August 10 at 12:04 PM
tmcnet.com logoVivek Jayaraman Appointed as Cerus Corporation's Chief Commercial Officer (NASDAQ:ELGX)
it.tmcnet.com - August 9 at 3:28 PM
capitalcube.com logoEndologix, Inc. :ELGX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 9 at 3:28 PM
capitalcube.com logoETF’s with exposure to Endologix, Inc. : August 5, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 5 at 4:51 PM
streetupdates.com logoAnalysts Observing Trading Stocks: Endologix, Inc. (NASDAQ:ELGX) , UnitedHealth Group Incorporated (NYSE:UNH) - Street Updates (NASDAQ:ELGX)
www.streetupdates.com - August 5 at 7:47 AM
equities.com logoEndologix Inc. (ELGX) Drops 12.84% on August 03 - Equities.com (NASDAQ:ELGX)
www.equities.com - August 5 at 7:47 AM
biz.yahoo.com logoENDOLOGIX INC /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:ELGX)
biz.yahoo.com - August 5 at 7:47 AM
nasdaq.com logoCommit To Purchase Endologix At $10, Earn 12% Annualized Using Options (NASDAQ:ELGX)
www.nasdaq.com - August 4 at 5:01 PM
capitalcube.com logoEndologix, Inc. breached its 50 day moving average in a Bearish Manner : ELGX-US : August 4, 2016 (NASDAQ:ELGX)
www.capitalcube.com - August 4 at 5:01 PM
finance.yahoo.com logoEndologix to Present at the 36th Annual Canaccord Genuity Growth Conference (NASDAQ:ELGX)
finance.yahoo.com - August 4 at 5:01 PM
fortune.com logoWhy Endologix, Inc. (NASDAQ:ELGX) have been downgraded? - Review Fortune (NASDAQ:ELGX)
reviewfortune.com - August 4 at 7:31 AM
News IconRussia: United States covering up election intrigue by demonising country (NASDAQ:ELGX)
bolsafinanzas.com - August 3 at 4:58 PM
benzinga.com logoPiper Jaffray Rates Endologix Overweight, Thinks Nellix Aneurysm Treatment Is 'Highly Approvable' (NASDAQ:ELGX)
www.benzinga.com - August 3 at 4:58 PM
News IconEndologix Inc. (ELGX) to Release Earnings on Tuesday (NASDAQ:ELGX)
learningandfinance.com - August 3 at 4:58 PM
thestreet.com logoWhy Endologix (ELGX) Stock Is Tumbling Today (NASDAQ:ELGX)
www.thestreet.com - August 3 at 4:58 PM
fool.com logoWhy Endologix, Inc. Is Down 13% Today (NASDAQ:ELGX)
www.fool.com - August 3 at 4:43 PM
seekingalpha.com logoEndologix tumbles on possible product delay (NASDAQ:ELGX)
seekingalpha.com - August 3 at 12:46 PM
streetupdates.com logoTraders Focused Stocks: EPIRUS Biopharmaceuticals, Inc ... - Street Updates (NASDAQ:ELGX)
www.streetupdates.com - August 2 at 10:24 PM
sg.finance.yahoo.com logoEndologix reports 2Q loss (NASDAQ:ELGX)
sg.finance.yahoo.com - August 2 at 10:24 PM

Social

Endologix (NASDAQ:ELGX) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff